

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.03698222 |
| 2 | cell adhesion mediated by integrin (GO:0033627) | 4.11569851 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 4.09388733 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.09388733 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.09388733 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.09388733 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.09388733 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.09388733 |
| 9 | desmosome organization (GO:0002934) | 3.87366113 |
| 10 | * glomerular visceral epithelial cell development (GO:0072015) | 3.79854121 |
| 11 | positive regulation of interferon-alpha production (GO:0032727) | 3.69840363 |
| 12 | cell-substrate junction assembly (GO:0007044) | 3.67520281 |
| 13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.65736838 |
| 14 | COPI coating of Golgi vesicle (GO:0048205) | 3.57795538 |
| 15 | Golgi transport vesicle coating (GO:0048200) | 3.57795538 |
| 16 | barbed-end actin filament capping (GO:0051016) | 3.56605609 |
| 17 | epithelial cell-cell adhesion (GO:0090136) | 3.56394228 |
| 18 | regulation of interferon-alpha production (GO:0032647) | 3.55476480 |
| 19 | * glomerular epithelial cell development (GO:0072310) | 3.52360215 |
| 20 | apoptotic cell clearance (GO:0043277) | 3.45604875 |
| 21 | wound healing, spreading of epidermal cells (GO:0035313) | 3.45263029 |
| 22 | regulation of vitamin metabolic process (GO:0030656) | 3.37686701 |
| 23 | glycosphingolipid catabolic process (GO:0046479) | 3.24702794 |
| 24 | regulation of cholesterol storage (GO:0010885) | 3.22184459 |
| 25 | macrophage activation involved in immune response (GO:0002281) | 3.20930257 |
| 26 | regulation of early endosome to late endosome transport (GO:2000641) | 3.18924976 |
| 27 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.17143047 |
| 28 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.16086610 |
| 29 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.13672963 |
| 30 | response to laminar fluid shear stress (GO:0034616) | 3.11142839 |
| 31 | positive regulation of p38MAPK cascade (GO:1900745) | 3.08821617 |
| 32 | stress fiber assembly (GO:0043149) | 3.08225621 |
| 33 | low-density lipoprotein particle clearance (GO:0034383) | 3.05747177 |
| 34 | adhesion of symbiont to host (GO:0044406) | 2.98567665 |
| 35 | protein localization to endosome (GO:0036010) | 2.98234206 |
| 36 | positive regulation of extracellular matrix organization (GO:1903055) | 2.95390528 |
| 37 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.93310366 |
| 38 | glycolipid catabolic process (GO:0019377) | 2.91637722 |
| 39 | skin morphogenesis (GO:0043589) | 2.91612338 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.89570859 |
| 41 | protein carboxylation (GO:0018214) | 2.89570859 |
| 42 | adhesion of symbiont to host cell (GO:0044650) | 2.85922166 |
| 43 | virion attachment to host cell (GO:0019062) | 2.85922166 |
| 44 | activation of Rac GTPase activity (GO:0032863) | 2.85037168 |
| 45 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.82310410 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80980907 |
| 47 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.79739350 |
| 48 | focal adhesion assembly (GO:0048041) | 2.79060292 |
| 49 | cell-substrate adherens junction assembly (GO:0007045) | 2.79060292 |
| 50 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.78404412 |
| 51 | adherens junction assembly (GO:0034333) | 2.77605366 |
| 52 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.76896279 |
| 53 | urea cycle (GO:0000050) | 2.75950720 |
| 54 | negative regulation of anoikis (GO:2000811) | 2.75664687 |
| 55 | hypotonic response (GO:0006971) | 2.74314204 |
| 56 | wound healing, spreading of cells (GO:0044319) | 2.72868241 |
| 57 | oligosaccharide catabolic process (GO:0009313) | 2.72154418 |
| 58 | membrane protein ectodomain proteolysis (GO:0006509) | 2.71883209 |
| 59 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.71730204 |
| 60 | neutrophil activation involved in immune response (GO:0002283) | 2.71455152 |
| 61 | fibrinolysis (GO:0042730) | 2.68089678 |
| 62 | I-kappaB phosphorylation (GO:0007252) | 2.66578174 |
| 63 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.63456633 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 2.63014889 |
| 65 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.62673573 |
| 66 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.62520034 |
| 67 | protein hydroxylation (GO:0018126) | 2.61893606 |
| 68 | positive regulation of interferon-beta production (GO:0032728) | 2.60784732 |
| 69 | hemidesmosome assembly (GO:0031581) | 2.59107248 |
| 70 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.58948381 |
| 71 | regulation of anoikis (GO:2000209) | 2.56204121 |
| 72 | regulation of mononuclear cell migration (GO:0071675) | 2.55534103 |
| 73 | hyaluronan catabolic process (GO:0030214) | 2.55117232 |
| 74 | regulation of integrin activation (GO:0033623) | 2.54379139 |
| 75 | sphingosine metabolic process (GO:0006670) | 2.52984039 |
| 76 | nuclear pore complex assembly (GO:0051292) | 2.52510011 |
| 77 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.52138406 |
| 78 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.51739363 |
| 79 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.51699160 |
| 80 | urea metabolic process (GO:0019627) | 2.51421215 |
| 81 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.50288200 |
| 82 | positive regulation of hemostasis (GO:1900048) | 2.50239236 |
| 83 | positive regulation of blood coagulation (GO:0030194) | 2.50239236 |
| 84 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.49519934 |
| 85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.49144737 |
| 86 | cellular response to vitamin D (GO:0071305) | 2.48981584 |
| 87 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 2.47648797 |
| 88 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.47288373 |
| 89 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.47216657 |
| 90 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.47216657 |
| 91 | endodermal cell differentiation (GO:0035987) | 2.46590325 |
| 92 | actin filament bundle assembly (GO:0051017) | 2.45757718 |
| 93 | actin filament bundle organization (GO:0061572) | 2.45757718 |
| 94 | T-helper 1 type immune response (GO:0042088) | 2.45047339 |
| 95 | peptidyl-proline hydroxylation (GO:0019511) | 2.44932764 |
| 96 | regulation of podosome assembly (GO:0071801) | 2.44844309 |
| 97 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.44213067 |
| 98 | regulation of cholesterol homeostasis (GO:2000188) | 2.43110862 |
| 99 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.42565622 |
| 100 | positive regulation of coagulation (GO:0050820) | 2.42241158 |
| 101 | response to fluid shear stress (GO:0034405) | 2.41743939 |
| 102 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.41011623 |
| 103 | immunoglobulin mediated immune response (GO:0016064) | 2.40812759 |
| 104 | gap junction assembly (GO:0016264) | 2.39515528 |
| 105 | * glomerular basement membrane development (GO:0032836) | 2.39157134 |
| 106 | iron ion import (GO:0097286) | 2.38462980 |
| 107 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.38284828 |
| 108 | ceramide catabolic process (GO:0046514) | 2.38185717 |
| 109 | basement membrane organization (GO:0071711) | 2.37764315 |
| 110 | response to host immune response (GO:0052572) | 2.37462528 |
| 111 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.37462528 |
| 112 | decidualization (GO:0046697) | 2.37448528 |
| 113 | activation of MAPKKK activity (GO:0000185) | 2.36431294 |
| 114 | collagen metabolic process (GO:0032963) | 2.36225841 |
| 115 | NIK/NF-kappaB signaling (GO:0038061) | 2.35942554 |
| 116 | COPII vesicle coating (GO:0048208) | 2.35867989 |
| 117 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.35826621 |
| 118 | embryonic process involved in female pregnancy (GO:0060136) | 2.35774059 |
| 119 | semaphorin-plexin signaling pathway (GO:0071526) | 2.35306024 |
| 120 | negative regulation of fibrinolysis (GO:0051918) | 2.34817902 |
| 121 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.34682926 |
| 122 | extracellular matrix disassembly (GO:0022617) | 2.31863994 |
| 123 | phospholipid efflux (GO:0033700) | 2.30240125 |
| 124 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.29855085 |
| 125 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.28907734 |
| 126 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.28536069 |
| 127 | regulation of macrophage chemotaxis (GO:0010758) | 2.28326110 |
| 128 | mannose metabolic process (GO:0006013) | 2.27587393 |
| 129 | response to vitamin D (GO:0033280) | 2.27570497 |
| 130 | macrophage activation (GO:0042116) | 2.27245082 |
| 131 | response to host (GO:0075136) | 2.27006137 |
| 132 | response to host defenses (GO:0052200) | 2.27006137 |
| 133 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.27006137 |
| 134 | collagen catabolic process (GO:0030574) | 2.26998832 |
| 135 | endocytic recycling (GO:0032456) | 2.25834028 |
| 136 | pinocytosis (GO:0006907) | 2.25400137 |
| 137 | multicellular organismal metabolic process (GO:0044236) | 2.25279025 |
| 138 | lipoprotein metabolic process (GO:0042157) | 2.24498107 |
| 139 | osteoclast differentiation (GO:0030316) | 2.24235868 |
| 140 | negative regulation of lipid storage (GO:0010888) | 2.24151008 |
| 141 | regulation of water loss via skin (GO:0033561) | 2.23373310 |
| 142 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.22486185 |
| 143 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.21651249 |
| 144 | positive regulation of lipid storage (GO:0010884) | 2.21205250 |
| 145 | substrate-dependent cell migration (GO:0006929) | 2.21075913 |
| 146 | endothelial cell morphogenesis (GO:0001886) | 2.18321279 |
| 147 | regulation of protein activation cascade (GO:2000257) | 2.18141248 |
| 148 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.18002653 |
| 149 | lipoprotein transport (GO:0042953) | 2.17594122 |
| 150 | complement activation, alternative pathway (GO:0006957) | 2.16374881 |
| 151 | cellular response to interferon-alpha (GO:0035457) | 2.16373334 |
| 152 | positive regulation of antigen processing and presentation (GO:0002579) | 2.16265736 |
| 153 | negative regulation of fatty acid transport (GO:2000192) | 2.16001592 |
| 154 | negative regulation of interleukin-8 production (GO:0032717) | 2.15709845 |
| 155 | regulation of complement activation (GO:0030449) | 2.15057822 |
| 156 | membrane raft organization (GO:0031579) | 2.14720009 |
| 157 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.14618929 |
| 158 | positive regulation of macrophage cytokine production (GO:0060907) | 2.14408176 |
| 159 | surfactant homeostasis (GO:0043129) | 2.12755555 |
| 160 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.12418407 |
| 161 | microglial cell activation (GO:0001774) | 2.12297716 |
| 162 | phospholipid homeostasis (GO:0055091) | 2.12118330 |
| 163 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.11511869 |
| 164 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.09803878 |
| 165 | granulocyte activation (GO:0036230) | 2.09558250 |
| 166 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.09431638 |
| 167 | regulation of macrophage cytokine production (GO:0010935) | 2.08750909 |
| 168 | positive regulation vascular endothelial growth factor production (GO:0010575) | 2.07136519 |
| 169 | neutrophil activation (GO:0042119) | 2.06817526 |
| 170 | integrin-mediated signaling pathway (GO:0007229) | 2.05643922 |
| 171 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.05300715 |
| 172 | respiratory burst (GO:0045730) | 2.05150069 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.40290869 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.81343171 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.46638786 |
| 4 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.21389688 |
| 5 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.13479349 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.03197680 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.98553296 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.91090864 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.72482082 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.68305523 |
| 11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.64890220 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61666202 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.59468518 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.55869236 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43290425 |
| 16 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.41770482 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40888386 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.30783039 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25637343 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.25208453 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.20093609 |
| 22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.10418174 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.06085296 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.00141420 |
| 25 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.94265567 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.86593412 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85323938 |
| 28 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79000912 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.77477965 |
| 30 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74902320 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70717011 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.69302581 |
| 33 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.67322984 |
| 34 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.66158253 |
| 35 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.66158253 |
| 36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64113293 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.64077851 |
| 38 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.61272328 |
| 39 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.60709714 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.59794951 |
| 41 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59077586 |
| 42 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.58586815 |
| 43 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56799217 |
| 44 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.54201065 |
| 45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.50531468 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.50506791 |
| 47 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.48751526 |
| 48 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.46365899 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45103016 |
| 50 | MYC_22102868_ChIP-Seq_BL_Human | 1.43525124 |
| 51 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41190577 |
| 52 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40597765 |
| 53 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.36526688 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.36354942 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.35979282 |
| 56 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.35017587 |
| 57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.34208275 |
| 58 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.32640676 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.32353684 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32044749 |
| 61 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31784131 |
| 62 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.29369073 |
| 63 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27802227 |
| 64 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25589298 |
| 65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.24973001 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24442117 |
| 67 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.24354545 |
| 68 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24125074 |
| 69 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.23952140 |
| 70 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.22860689 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18778676 |
| 72 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17420041 |
| 73 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16590749 |
| 74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16302705 |
| 75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16302705 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16159742 |
| 77 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16028313 |
| 78 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15149940 |
| 79 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.14830473 |
| 80 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.14566845 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13857623 |
| 82 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.12920408 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12052256 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.11707189 |
| 85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11341965 |
| 86 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11341965 |
| 87 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10595868 |
| 88 | SPI1_23127762_ChIP-Seq_K562_Human | 1.10230407 |
| 89 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09517077 |
| 90 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08764068 |
| 91 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08597239 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08102566 |
| 93 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07559299 |
| 94 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.07299579 |
| 95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.06901761 |
| 96 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06437785 |
| 97 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.06262478 |
| 98 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04554477 |
| 99 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.03796282 |
| 100 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.03416160 |
| 101 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01493389 |
| 102 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01262690 |
| 103 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00908285 |
| 104 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99288801 |
| 105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.98779375 |
| 106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98344116 |
| 107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98027616 |
| 108 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97986601 |
| 109 | MAF_26560356_Chip-Seq_TH1_Human | 0.97903652 |
| 110 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.97154893 |
| 111 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96082686 |
| 112 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95520108 |
| 113 | KDM2B_26808549_Chip-Seq_K562_Human | 0.95488024 |
| 114 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.95176321 |
| 115 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94824084 |
| 116 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94772858 |
| 117 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.94580123 |
| 118 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.94139698 |
| 119 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.93665879 |
| 120 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91936621 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91763049 |
| 122 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.91734750 |
| 123 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.91016149 |
| 124 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90635150 |
| 125 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.90047413 |
| 126 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89824655 |
| 127 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.89277182 |
| 128 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88860417 |
| 129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.88466033 |
| 130 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.87975323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.09410725 |
| 2 | MP0003303_peritoneal_inflammation | 2.90970451 |
| 3 | MP0002877_abnormal_melanocyte_morpholog | 2.85971675 |
| 4 | MP0003566_abnormal_cell_adhesion | 2.50757973 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 2.49697531 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.45003912 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.23289223 |
| 8 | MP0005360_urolithiasis | 2.19768622 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.17034821 |
| 10 | MP0003436_decreased_susceptibility_to | 2.14316508 |
| 11 | MP0010234_abnormal_vibrissa_follicle | 2.10966590 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.10007944 |
| 13 | MP0009840_abnormal_foam_cell | 2.04195791 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 1.98139399 |
| 15 | MP0005275_abnormal_skin_tensile | 1.97495035 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 1.96512180 |
| 17 | MP0005451_abnormal_body_composition | 1.83836662 |
| 18 | MP0004947_skin_inflammation | 1.81635117 |
| 19 | MP0005257_abnormal_intraocular_pressure | 1.80456581 |
| 20 | MP0005023_abnormal_wound_healing | 1.79665444 |
| 21 | MP0005387_immune_system_phenotype | 1.78046066 |
| 22 | MP0001790_abnormal_immune_system | 1.78046066 |
| 23 | MP0002254_reproductive_system_inflammat | 1.71049891 |
| 24 | MP0001849_ear_inflammation | 1.70738150 |
| 25 | MP0003091_abnormal_cell_migration | 1.65470690 |
| 26 | MP0002419_abnormal_innate_immunity | 1.63442817 |
| 27 | MP0006082_CNS_inflammation | 1.61500080 |
| 28 | MP0003453_abnormal_keratinocyte_physiol | 1.57837774 |
| 29 | MP0001958_emphysema | 1.53602951 |
| 30 | MP0005000_abnormal_immune_tolerance | 1.50845700 |
| 31 | MP0001800_abnormal_humoral_immune | 1.48519574 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.48299181 |
| 33 | MP0001533_abnormal_skeleton_physiology | 1.47636792 |
| 34 | MP0003252_abnormal_bile_duct | 1.46052051 |
| 35 | MP0004272_abnormal_basement_membrane | 1.43896865 |
| 36 | MP0005076_abnormal_cell_differentiation | 1.43721409 |
| 37 | MP0000685_abnormal_immune_system | 1.42391888 |
| 38 | MP0003279_aneurysm | 1.41653392 |
| 39 | MP0005085_abnormal_gallbladder_physiolo | 1.41286809 |
| 40 | MP0000579_abnormal_nail_morphology | 1.41016323 |
| 41 | MP0005501_abnormal_skin_physiology | 1.35416965 |
| 42 | MP0002138_abnormal_hepatobiliary_system | 1.35246518 |
| 43 | MP0005409_darkened_coat_color | 1.30891957 |
| 44 | MP0002060_abnormal_skin_morphology | 1.30314837 |
| 45 | MP0002796_impaired_skin_barrier | 1.30206246 |
| 46 | MP0003448_altered_tumor_morphology | 1.26057474 |
| 47 | MP0002896_abnormal_bone_mineralization | 1.25772769 |
| 48 | MP0005083_abnormal_biliary_tract | 1.24974107 |
| 49 | MP0004233_abnormal_muscle_weight | 1.23377306 |
| 50 | MP0005365_abnormal_bile_salt | 1.22407461 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.21948088 |
| 52 | MP0002933_joint_inflammation | 1.21568515 |
| 53 | MP0005025_abnormal_response_to | 1.21312105 |
| 54 | MP0002998_abnormal_bone_remodeling | 1.20578697 |
| 55 | MP0000003_abnormal_adipose_tissue | 1.17046271 |
| 56 | MP0006054_spinal_hemorrhage | 1.16744212 |
| 57 | MP0002723_abnormal_immune_serum | 1.16417505 |
| 58 | MP0003724_increased_susceptibility_to | 1.15322723 |
| 59 | MP0005623_abnormal_meninges_morphology | 1.14330087 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.11986023 |
| 61 | MP0005464_abnormal_platelet_physiology | 1.11857500 |
| 62 | MP0000013_abnormal_adipose_tissue | 1.11822538 |
| 63 | * MP0000767_abnormal_smooth_muscle | 1.10872832 |
| 64 | MP0010368_abnormal_lymphatic_system | 1.10840365 |
| 65 | MP0001845_abnormal_inflammatory_respons | 1.10257572 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.10237526 |
| 67 | MP0009785_altered_susceptibility_to | 1.08635121 |
| 68 | MP0001879_abnormal_lymphatic_vessel | 1.08314132 |
| 69 | MP0008875_abnormal_xenobiotic_pharmacok | 1.07156325 |
| 70 | MP0005165_increased_susceptibility_to | 1.06601839 |
| 71 | MP0000604_amyloidosis | 1.04595620 |
| 72 | MP0001666_abnormal_nutrient_absorption | 1.03350606 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.02204748 |
| 74 | MP0010155_abnormal_intestine_physiology | 0.99925037 |
| 75 | MP0002405_respiratory_system_inflammati | 0.99787683 |
| 76 | MP0000609_abnormal_liver_physiology | 0.99282212 |
| 77 | MP0003806_abnormal_nucleotide_metabolis | 0.99118042 |
| 78 | MP0005390_skeleton_phenotype | 0.98717727 |
| 79 | MP0001873_stomach_inflammation | 0.98586051 |
| 80 | MP0001819_abnormal_immune_cell | 0.98344726 |
| 81 | MP0002420_abnormal_adaptive_immunity | 0.98343779 |
| 82 | MP0008260_abnormal_autophagy | 0.98132253 |
| 83 | * MP0002136_abnormal_kidney_physiology | 0.97980576 |
| 84 | MP0000858_altered_metastatic_potential | 0.97469356 |
| 85 | MP0009384_cardiac_valve_regurgitation | 0.97148628 |
| 86 | MP0005621_abnormal_cell_physiology | 0.96380551 |
| 87 | MP0008469_abnormal_protein_level | 0.96347703 |
| 88 | MP0003183_abnormal_peptide_metabolism | 0.95832227 |
| 89 | MP0000762_abnormal_tongue_morphology | 0.95677039 |
| 90 | MP0001243_abnormal_dermal_layer | 0.95645767 |
| 91 | MP0004858_abnormal_nervous_system | 0.95446309 |
| 92 | MP0001853_heart_inflammation | 0.95173351 |
| 93 | MP0005166_decreased_susceptibility_to | 0.93981340 |
| 94 | MP0003941_abnormal_skin_development | 0.93476190 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.93252728 |
| 96 | MP0002295_abnormal_pulmonary_circulatio | 0.92778319 |
| 97 | MP0009278_abnormal_bone_marrow | 0.92290902 |
| 98 | MP0003075_altered_response_to | 0.92098371 |
| 99 | MP0003045_fibrosis | 0.91857831 |
| 100 | MP0004510_myositis | 0.91692846 |
| 101 | MP0002166_altered_tumor_susceptibility | 0.91460463 |
| 102 | MP0010307_abnormal_tumor_latency | 0.91297125 |
| 103 | MP0000343_altered_response_to | 0.91283866 |
| 104 | MP0002168_other_aberrant_phenotype | 0.90901550 |
| 105 | MP0001915_intracranial_hemorrhage | 0.90187526 |
| 106 | MP0003828_pulmonary_edema | 0.90100366 |
| 107 | MP0010678_abnormal_skin_adnexa | 0.89306935 |
| 108 | MP0001216_abnormal_epidermal_layer | 0.89262730 |
| 109 | MP0004782_abnormal_surfactant_physiolog | 0.89200562 |
| 110 | MP0000733_abnormal_muscle_development | 0.89047100 |
| 111 | MP0005164_abnormal_response_to | 0.88416187 |
| 112 | MP0000249_abnormal_blood_vessel | 0.87887085 |
| 113 | MP0000569_abnormal_digit_pigmentation | 0.87656368 |
| 114 | MP0005503_abnormal_tendon_morphology | 0.86657806 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.86394820 |
| 116 | MP0009764_decreased_sensitivity_to | 0.85682504 |
| 117 | MP0004185_abnormal_adipocyte_glucose | 0.84730053 |
| 118 | MP0001348_abnormal_lacrimal_gland | 0.84716273 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.84268390 |
| 120 | MP0000371_diluted_coat_color | 0.82538588 |
| 121 | MP0000383_abnormal_hair_follicle | 0.81946637 |
| 122 | MP0005197_abnormal_uvea_morphology | 0.79962276 |
| 123 | MP0010771_integument_phenotype | 0.79297677 |
| 124 | MP0000467_abnormal_esophagus_morphology | 0.78459524 |
| 125 | MP0000490_abnormal_crypts_of | 0.78110600 |
| 126 | MP0004264_abnormal_extraembryonic_tissu | 0.72136257 |
| 127 | MP0005248_abnormal_Harderian_gland | 0.70078117 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.69733023 |
| 129 | MP0000627_abnormal_mammary_gland | 0.69236796 |
| 130 | MP0001191_abnormal_skin_condition | 0.68748402 |
| 131 | MP0003868_abnormal_feces_composition | 0.68399934 |
| 132 | MP0000377_abnormal_hair_follicle | 0.68264409 |
| 133 | MP0001542_abnormal_bone_strength | 0.67832424 |
| 134 | MP0004808_abnormal_hematopoietic_stem | 0.66962511 |
| 135 | MP0002098_abnormal_vibrissa_morphology | 0.65998133 |
| 136 | MP0000537_abnormal_urethra_morphology | 0.65897629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myocardial infarction (HP:0001658) | 4.08052078 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 3.55365973 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.55365973 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.55365973 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.21465688 |
| 6 | Natal tooth (HP:0000695) | 3.07490970 |
| 7 | Premature rupture of membranes (HP:0001788) | 3.07394325 |
| 8 | Xanthomatosis (HP:0000991) | 3.05020757 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.03706324 |
| 10 | Recurrent abscess formation (HP:0002722) | 2.96546077 |
| 11 | Deep venous thrombosis (HP:0002625) | 2.93666825 |
| 12 | Glomerulonephritis (HP:0000099) | 2.92338476 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 2.91778237 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 2.88471793 |
| 15 | Axonal loss (HP:0003447) | 2.87850617 |
| 16 | Arterial tortuosity (HP:0005116) | 2.87430618 |
| 17 | Spondylolisthesis (HP:0003302) | 2.80355144 |
| 18 | Nephritis (HP:0000123) | 2.74361985 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 2.73151117 |
| 20 | Vascular tortuosity (HP:0004948) | 2.71688503 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 2.71463959 |
| 22 | Protrusio acetabuli (HP:0003179) | 2.70439069 |
| 23 | Interstitial pulmonary disease (HP:0006530) | 2.69229417 |
| 24 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.67856503 |
| 25 | Osteolytic defects of the hand bones (HP:0009699) | 2.67856503 |
| 26 | Fragile skin (HP:0001030) | 2.62999493 |
| 27 | Hematochezia (HP:0002573) | 2.62839982 |
| 28 | Short nail (HP:0001799) | 2.62080755 |
| 29 | Intrahepatic cholestasis (HP:0001406) | 2.61422695 |
| 30 | Hyperacusis (HP:0010780) | 2.57673771 |
| 31 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.55066938 |
| 32 | Aortic aneurysm (HP:0004942) | 2.53570841 |
| 33 | Esophageal varix (HP:0002040) | 2.53461213 |
| 34 | Milia (HP:0001056) | 2.51809078 |
| 35 | Wormian bones (HP:0002645) | 2.49993257 |
| 36 | Complement deficiency (HP:0004431) | 2.47031620 |
| 37 | Peritonitis (HP:0002586) | 2.46776628 |
| 38 | Cervical subluxation (HP:0003308) | 2.45733376 |
| 39 | Thin bony cortex (HP:0002753) | 2.43212925 |
| 40 | Tetraparesis (HP:0002273) | 2.42046208 |
| 41 | Nuclear cataract (HP:0100018) | 2.41831546 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.41797449 |
| 43 | Malnutrition (HP:0004395) | 2.41572427 |
| 44 | Abnormality of complement system (HP:0005339) | 2.39374992 |
| 45 | Cerebral aneurysm (HP:0004944) | 2.36137170 |
| 46 | Autoimmune thrombocytopenia (HP:0001973) | 2.36040763 |
| 47 | Cupped ribs (HP:0000887) | 2.35388030 |
| 48 | Atrophic scars (HP:0001075) | 2.34035214 |
| 49 | Aortic dissection (HP:0002647) | 2.33759310 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.30961884 |
| 51 | Thick nail (HP:0001805) | 2.28889514 |
| 52 | Mucopolysacchariduria (HP:0008155) | 2.28373329 |
| 53 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.28373329 |
| 54 | Mitral stenosis (HP:0001718) | 2.25655624 |
| 55 | * Focal segmental glomerulosclerosis (HP:0000097) | 2.24670200 |
| 56 | Onycholysis (HP:0001806) | 2.23976733 |
| 57 | Broad face (HP:0000283) | 2.21721568 |
| 58 | Plantar hyperkeratosis (HP:0007556) | 2.21346623 |
| 59 | Ulnar bowing (HP:0003031) | 2.19227485 |
| 60 | Neurofibrillary tangles (HP:0002185) | 2.18383483 |
| 61 | Loss of speech (HP:0002371) | 2.17002926 |
| 62 | Distal lower limb amyotrophy (HP:0008944) | 2.16450924 |
| 63 | Achilles tendon contracture (HP:0001771) | 2.16268565 |
| 64 | Joint hemorrhage (HP:0005261) | 2.15801659 |
| 65 | Mesangial abnormality (HP:0001966) | 2.14637661 |
| 66 | Bladder diverticulum (HP:0000015) | 2.13631008 |
| 67 | Advanced eruption of teeth (HP:0006288) | 2.13516235 |
| 68 | Pustule (HP:0200039) | 2.12895390 |
| 69 | Elbow flexion contracture (HP:0002987) | 2.11960220 |
| 70 | Alopecia of scalp (HP:0002293) | 2.10293308 |
| 71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08831090 |
| 72 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08831090 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08831090 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.08202001 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.08202001 |
| 76 | Vertebral compression fractures (HP:0002953) | 2.07914884 |
| 77 | Hypoalphalipoproteinemia (HP:0003233) | 2.07427879 |
| 78 | Cellulitis (HP:0100658) | 2.07243836 |
| 79 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05979043 |
| 80 | Abnormal foot bone ossification (HP:0010675) | 2.04254883 |
| 81 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.04168615 |
| 82 | Gastrointestinal stroma tumor (HP:0100723) | 2.03712245 |
| 83 | Increased connective tissue (HP:0009025) | 2.03002689 |
| 84 | Abnormal tarsal ossification (HP:0008369) | 2.02256354 |
| 85 | Flat acetabular roof (HP:0003180) | 2.01714116 |
| 86 | Epidermoid cyst (HP:0200040) | 2.00580316 |
| 87 | Right ventricular cardiomyopathy (HP:0011663) | 2.00488634 |
| 88 | Mitral valve prolapse (HP:0001634) | 2.00003421 |
| 89 | Abnormality of the Achilles tendon (HP:0005109) | 1.98824806 |
| 90 | Tibial bowing (HP:0002982) | 1.97870331 |
| 91 | Selective tooth agenesis (HP:0001592) | 1.94600532 |
| 92 | Metaphyseal cupping (HP:0003021) | 1.93910252 |
| 93 | Hyperlipoproteinemia (HP:0010980) | 1.93654648 |
| 94 | Abnormality of nail color (HP:0100643) | 1.93209849 |
| 95 | Hypercholesterolemia (HP:0003124) | 1.92697398 |
| 96 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.92411862 |
| 97 | IgA deficiency (HP:0002720) | 1.91572627 |
| 98 | Colitis (HP:0002583) | 1.91044929 |
| 99 | Upper limb amyotrophy (HP:0009129) | 1.90784612 |
| 100 | Distal upper limb amyotrophy (HP:0007149) | 1.90784612 |
| 101 | Entropion (HP:0000621) | 1.90217085 |
| 102 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.89886853 |
| 103 | Increased CSF protein (HP:0002922) | 1.89185452 |
| 104 | Cardiovascular calcification (HP:0011915) | 1.89157732 |
| 105 | Ovoid vertebral bodies (HP:0003300) | 1.89016505 |
| 106 | Abnormality of the acetabulum (HP:0003170) | 1.88784124 |
| 107 | Osteomyelitis (HP:0002754) | 1.88349757 |
| 108 | Persistence of primary teeth (HP:0006335) | 1.86583196 |
| 109 | Shallow orbits (HP:0000586) | 1.86368004 |
| 110 | Gingivitis (HP:0000230) | 1.85673220 |
| 111 | Increased mean platelet volume (HP:0011877) | 1.84415992 |
| 112 | Ridged nail (HP:0001807) | 1.84261375 |
| 113 | Periodontitis (HP:0000704) | 1.84059644 |
| 114 | Subacute progressive viral hepatitis (HP:0006572) | 1.83227483 |
| 115 | Mediastinal lymphadenopathy (HP:0100721) | 1.83036917 |
| 116 | Cerebral inclusion bodies (HP:0100314) | 1.82415324 |
| 117 | Protuberant abdomen (HP:0001538) | 1.82037714 |
| 118 | Abnormality of the lumbar spine (HP:0100712) | 1.81774435 |
| 119 | Distal lower limb muscle weakness (HP:0009053) | 1.81540089 |
| 120 | Ankle contracture (HP:0006466) | 1.80691898 |
| 121 | Emphysema (HP:0002097) | 1.79554629 |
| 122 | Nail dystrophy (HP:0008404) | 1.79352263 |
| 123 | Aneurysm (HP:0002617) | 1.79098413 |
| 124 | Vascular calcification (HP:0004934) | 1.77246172 |
| 125 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.77196162 |
| 126 | Peripheral demyelination (HP:0011096) | 1.76333320 |
| 127 | Upper motor neuron abnormality (HP:0002127) | 1.75827596 |
| 128 | * Glomerulosclerosis (HP:0000096) | 1.74901892 |
| 129 | Epiphyseal dysplasia (HP:0002656) | 1.74416398 |
| 130 | Recurrent skin infections (HP:0001581) | 1.74283734 |
| 131 | Pathologic fracture (HP:0002756) | 1.74134135 |
| 132 | Abnormality of the common coagulation pathway (HP:0010990) | 1.74044004 |
| 133 | Bone pain (HP:0002653) | 1.73518589 |
| 134 | Ankyloglossia (HP:0010296) | 1.73230073 |
| 135 | Blue sclerae (HP:0000592) | 1.72296992 |
| 136 | Abnormal platelet volume (HP:0011876) | 1.72194184 |
| 137 | Palmoplantar hyperkeratosis (HP:0000972) | 1.71984892 |
| 138 | Spinal rigidity (HP:0003306) | 1.71695491 |
| 139 | Dilatation of the ascending aorta (HP:0005111) | 1.71686344 |
| 140 | Hypoplastic ischia (HP:0003175) | 1.71300858 |
| 141 | Neonatal short-limb short stature (HP:0008921) | 1.71160587 |
| 142 | Thoracolumbar scoliosis (HP:0002944) | 1.71012862 |
| 143 | Camptodactyly of toe (HP:0001836) | 1.70870147 |
| 144 | Polycythemia (HP:0001901) | 1.70658815 |
| 145 | Conjunctival telangiectasia (HP:0000524) | 1.70493230 |
| 146 | Femoral bowing (HP:0002980) | 1.70142906 |
| 147 | Disinhibition (HP:0000734) | 1.70028409 |
| 148 | Vasculitis (HP:0002633) | 1.68286364 |
| 149 | Disproportionate tall stature (HP:0001519) | 1.67905807 |
| 150 | Fat malabsorption (HP:0002630) | 1.67891576 |
| 151 | Abnormal ossification of hand bones (HP:0005921) | 1.66847078 |
| 152 | Abnormality of carpal bone ossification (HP:0006257) | 1.64204915 |
| 153 | Aortic regurgitation (HP:0001659) | 1.64006706 |
| 154 | Absent frontal sinuses (HP:0002688) | 1.63001753 |
| 155 | Abnormality of oral frenula (HP:0000190) | 1.62732257 |
| 156 | Mitral regurgitation (HP:0001653) | 1.62011259 |
| 157 | Abnormality of dentin (HP:0010299) | 1.60399854 |
| 158 | Vertebral arch anomaly (HP:0008438) | 1.60109083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.25924158 |
| 2 | TBK1 | 2.66165896 |
| 3 | TRIB3 | 2.31157782 |
| 4 | PRPF4B | 2.16399735 |
| 5 | NME2 | 2.16292653 |
| 6 | EPHB1 | 2.13953720 |
| 7 | TGFBR2 | 2.13182922 |
| 8 | MAP3K14 | 2.09689438 |
| 9 | LATS2 | 2.09045971 |
| 10 | EEF2K | 2.06515363 |
| 11 | SMG1 | 1.96552039 |
| 12 | MST4 | 1.96132937 |
| 13 | STK10 | 1.93524185 |
| 14 | FGFR4 | 1.92102868 |
| 15 | TYK2 | 1.90743468 |
| 16 | MAP4K1 | 1.88957196 |
| 17 | TTN | 1.87848717 |
| 18 | EPHA2 | 1.86818508 |
| 19 | IRAK3 | 1.85462275 |
| 20 | MST1R | 1.81723177 |
| 21 | LATS1 | 1.81660683 |
| 22 | LRRK2 | 1.76467838 |
| 23 | PDK2 | 1.75243931 |
| 24 | NEK9 | 1.74312513 |
| 25 | MAP3K3 | 1.70227665 |
| 26 | PTK6 | 1.68850770 |
| 27 | RIPK1 | 1.68673761 |
| 28 | SIK1 | 1.64274599 |
| 29 | JAK1 | 1.64007863 |
| 30 | ICK | 1.62723437 |
| 31 | BLK | 1.61348447 |
| 32 | KIT | 1.55662563 |
| 33 | MOS | 1.47556541 |
| 34 | CDK12 | 1.47040924 |
| 35 | IKBKB | 1.44911987 |
| 36 | CDC42BPA | 1.43961414 |
| 37 | EPHA3 | 1.42653600 |
| 38 | DDR2 | 1.37440066 |
| 39 | STK3 | 1.34495744 |
| 40 | CSK | 1.33898997 |
| 41 | MAP3K9 | 1.33542447 |
| 42 | IKBKE | 1.33116772 |
| 43 | FGFR3 | 1.32055055 |
| 44 | FRK | 1.29845291 |
| 45 | MET | 1.27120175 |
| 46 | CAMK1D | 1.24641352 |
| 47 | RIPK4 | 1.24569221 |
| 48 | TRPM7 | 1.20949368 |
| 49 | CSF1R | 1.20088123 |
| 50 | EPHB2 | 1.19476047 |
| 51 | BMX | 1.19295653 |
| 52 | ARAF | 1.18853882 |
| 53 | CHUK | 1.15174165 |
| 54 | PKN2 | 1.14007855 |
| 55 | LMTK2 | 1.11965124 |
| 56 | PIM2 | 1.09841715 |
| 57 | JAK3 | 1.09729797 |
| 58 | PBK | 1.09052051 |
| 59 | MELK | 1.09038021 |
| 60 | FER | 1.02323607 |
| 61 | MATK | 1.02163128 |
| 62 | PDGFRA | 1.02016036 |
| 63 | PAK4 | 1.01528309 |
| 64 | RPS6KA4 | 0.97093003 |
| 65 | MAP3K10 | 0.95845852 |
| 66 | MAP2K3 | 0.94201131 |
| 67 | GRK6 | 0.92377737 |
| 68 | PTK2 | 0.90992151 |
| 69 | CDK6 | 0.90336499 |
| 70 | TAOK2 | 0.89348634 |
| 71 | MAP3K2 | 0.86784762 |
| 72 | KDR | 0.86484291 |
| 73 | HCK | 0.86432018 |
| 74 | ACVR1B | 0.79155877 |
| 75 | MAPK11 | 0.79021123 |
| 76 | PDGFRB | 0.78125933 |
| 77 | PIM1 | 0.78076979 |
| 78 | DMPK | 0.77344159 |
| 79 | PRKG2 | 0.74722828 |
| 80 | MARK3 | 0.73954705 |
| 81 | ITK | 0.72853619 |
| 82 | EGFR | 0.72802007 |
| 83 | JAK2 | 0.69960551 |
| 84 | MAP2K2 | 0.69311194 |
| 85 | TAOK3 | 0.69298361 |
| 86 | PAK2 | 0.68909050 |
| 87 | MTOR | 0.66768686 |
| 88 | GSK3A | 0.66462261 |
| 89 | BRD4 | 0.66076358 |
| 90 | ERBB4 | 0.65119892 |
| 91 | ABL1 | 0.63187901 |
| 92 | EIF2AK3 | 0.61867036 |
| 93 | FGR | 0.61796515 |
| 94 | FGFR2 | 0.60626216 |
| 95 | CAMK1G | 0.60502750 |
| 96 | MAP3K8 | 0.59742263 |
| 97 | BMPR2 | 0.59192008 |
| 98 | ZAP70 | 0.58857060 |
| 99 | RPS6KA2 | 0.56781674 |
| 100 | MAP3K13 | 0.56654484 |
| 101 | MAP2K1 | 0.56120691 |
| 102 | LIMK1 | 0.54898936 |
| 103 | CDK9 | 0.53562401 |
| 104 | MAPK7 | 0.52851720 |
| 105 | TESK1 | 0.52147600 |
| 106 | PDPK1 | 0.51540544 |
| 107 | LYN | 0.51202393 |
| 108 | INSR | 0.50962031 |
| 109 | IGF1R | 0.50563901 |
| 110 | BTK | 0.50366095 |
| 111 | DYRK1B | 0.50232546 |
| 112 | LCK | 0.49947500 |
| 113 | STK38L | 0.49024569 |
| 114 | ABL2 | 0.48586224 |
| 115 | ERBB2 | 0.46150310 |
| 116 | NEK1 | 0.45723036 |
| 117 | SCYL2 | 0.45434403 |
| 118 | MAPKAPK2 | 0.45195501 |
| 119 | RPS6KB2 | 0.45151062 |
| 120 | PIK3CA | 0.44830254 |
| 121 | MYLK | 0.44655370 |
| 122 | PIK3CG | 0.44455707 |
| 123 | MAPKAPK3 | 0.44393368 |
| 124 | PRKD1 | 0.44271929 |
| 125 | TGFBR1 | 0.43838790 |
| 126 | MAP3K1 | 0.43396543 |
| 127 | SYK | 0.43262127 |
| 128 | STK24 | 0.42528390 |
| 129 | KSR2 | 0.42309246 |
| 130 | NTRK1 | 0.42150956 |
| 131 | MAPKAPK5 | 0.40062895 |
| 132 | DAPK3 | 0.39854275 |
| 133 | ROCK2 | 0.33150081 |
| 134 | BRAF | 0.32713871 |
| 135 | CDK4 | 0.31107146 |
| 136 | TTK | 0.30812292 |
| 137 | IRAK4 | 0.28431188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.76407776 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.46935567 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.89590491 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86785139 |
| 5 | Galactose metabolism_Homo sapiens_hsa00052 | 1.80034805 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.78680689 |
| 7 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.75825147 |
| 8 | Lysosome_Homo sapiens_hsa04142 | 1.73683783 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.72701786 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.71079755 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.70819675 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.69904543 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.64311833 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62614566 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61633400 |
| 16 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.54963905 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.52495834 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.52304766 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.50217333 |
| 20 | Pertussis_Homo sapiens_hsa05133 | 1.44808847 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.39078925 |
| 22 | Amoebiasis_Homo sapiens_hsa05146 | 1.37898260 |
| 23 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.35674692 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.31066510 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.30905778 |
| 26 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30846336 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.30787933 |
| 28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28681395 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.27246055 |
| 30 | Adherens junction_Homo sapiens_hsa04520 | 1.26752283 |
| 31 | Focal adhesion_Homo sapiens_hsa04510 | 1.25552117 |
| 32 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22626835 |
| 33 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.19328456 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.19226219 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.17939597 |
| 36 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.17802208 |
| 37 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17111485 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16757197 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 1.15566707 |
| 40 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.12087011 |
| 41 | Asthma_Homo sapiens_hsa05310 | 1.11207864 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 1.07977783 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.06794678 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06163179 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.05924576 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05633732 |
| 47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.04814170 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.04592080 |
| 49 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04010495 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03720985 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03658695 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03175245 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 1.01355313 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99384344 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96351751 |
| 56 | Shigellosis_Homo sapiens_hsa05131 | 0.95443658 |
| 57 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95228457 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.92176238 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.92006682 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.90978042 |
| 61 | Measles_Homo sapiens_hsa05162 | 0.88437853 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.87961725 |
| 63 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.87700732 |
| 64 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87243870 |
| 65 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86659239 |
| 66 | Mineral absorption_Homo sapiens_hsa04978 | 0.85139008 |
| 67 | Influenza A_Homo sapiens_hsa05164 | 0.83849729 |
| 68 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.82904911 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82825569 |
| 70 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82793313 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82104869 |
| 72 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.81535392 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.81407988 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79619639 |
| 75 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78946111 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78667170 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.78429743 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78029061 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76357284 |
| 80 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.76111480 |
| 81 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74537180 |
| 82 | Hepatitis B_Homo sapiens_hsa05161 | 0.74123908 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.74047001 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.73875682 |
| 85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.73095270 |
| 86 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73053094 |
| 87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72031726 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.70893072 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.68748749 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68283762 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.68172543 |
| 92 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67728082 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67441252 |
| 94 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66481571 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66193826 |
| 96 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.66003840 |
| 97 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.65054553 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63970939 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.63480252 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.62936496 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.61794914 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.61256078 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.60256086 |
| 104 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59761378 |
| 105 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58381870 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57989785 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.57155099 |
| 108 | HTLV-I infection_Homo sapiens_hsa05166 | 0.56443622 |
| 109 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55538156 |
| 110 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.55207895 |
| 111 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54682708 |
| 112 | Pathways in cancer_Homo sapiens_hsa05200 | 0.53721088 |
| 113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52786108 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52550683 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51441675 |
| 116 | Tight junction_Homo sapiens_hsa04530 | 0.49243579 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47789556 |
| 118 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47621538 |
| 119 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47552305 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47530304 |
| 121 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.46377831 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46055070 |
| 123 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.44959282 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44652373 |
| 125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43911850 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.43818859 |
| 127 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43064721 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42897308 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42796266 |

